biostudies-literatureUnknown22(2)Morgan RDCancer Research UKMedical Research CouncilNational Institute for Health Research (NIHR)Health Research BoardWellbeing of WomenThe Lancet. Oncology277-288https://www.ebi.ac.uk/biostudies/studies/S-EPMC7616995biostudies-literatureObjective responses to first-line neoadjuvant carboplatin-paclitaxel regimens for ovarian, fallopian tube, or primary peritoneal carcinoma (ICON8): post-hoc exploratory analysis of a randomised, phase 3 trial.PMC76169951969413034MC_UU_12023/20CA1489/A170929832RG1705G1100425MC_UU_12023/2517092MC_UU_12023/9C1489/A12127ICORG-2016-112127Sundar SPoole CJLord RGlasspool RMSummers JJames ECLedermann JAZachariah AWalther AJayson GCKrell JEssapen SLockley MClamp ARHall MGallardo-Rincon DCook ADMorgan RDScatchard KDark GParkinson CKim JWMcNeish IAJones RWilliams SAnand AfalseObjective responses to first-line neoadjuvant carboplatin-paclitaxel regimens for ovarian, fallopian tube, or primary peritoneal carcinoma (ICON8): post-hoc exploratory analysis of a randomised, phase 3 trial.2021-01-01T00:00:00Z2021 Feb2026-06-01T17:45:50.23Z2025-04-04T12:25:34.17ZS-EPMC76169953335751010.1016/s1470-2045(20)30591-x10.1016/S1470-2045(20)30591-X